2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Wuchereria Bancrofti Infection: new trials by email Literature Review of Wuchereria Bancrofti Infection trials Research Report on Wuchereria Bancrofti Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE) Ivermectin, Diethylcarbamazine Albendazole (IDA) - Wuchereria Bancrofti Infection | Phase 1 | Completed | University Hospitals Cleveland Medical Center | 66 | 2016-04-17 | 2019-04-26 |
| Effect of Albendazole Dose on Clearance of Filarial Worms DEC/Albendazole - Lymphatic Filariasis, Wuchereria Bancrofti Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1000 | 2006-09-09 | 2017-07-02 |
Elephantiasis, Filarial (2) · Enterobiasis (1)
Filariasis (2) · Helminthiasis (2) · Hemic and Lymphatic Diseases (2) · Infections (2) · Lymphatic Diseases (2) · Lymphedema (2) · Mosquito-Borne Diseases (2) · Nematode Infections (2) · Parasitic Diseases (2) · Secernentea Infections (2) · Spirurida Infections (2) · Vector Borne Diseases (2) · Oxyuriasis (1) · Oxyurida Infections (1)
Ivermectin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Hospitals Cleveland Medical Center (1)
Côte d’Ivoire (1) · India (1)